Patent · US Expired

Combination of azelastine and steroids

US8168620B2 · kind B2 · utility

19Cited by

70References

48Claims

0Family size

Assignee

Cipla Limited · IN

Inventors

Amar Lulla · Mumbai, IN
Geena Malhotra · Jamkhed, IN

Key dates

Filing date	Jun 13, 2003
Grant date	May 1, 2012
Priority date	—
Expiry date	Feb 24, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.